Document is current
Any future updates will be listed below
-
Authors
Nené, Nuno R.
Barrett, James
Jones, Allison
Evans, Iona
Reisel, Daniel
Timms, John F.
Paprotka, Tobias
Leimbach, Andreas
Franchi, Dorella
Colombo, Nicoletta
Bjørge, Line
Zikan, Michal
Cibula, David
Widschwendter, Martin http://orcid.org/0000-0002-7778-8380
-
Funding
Funding for this research was provided by:
Horizon 2020 Framework Programme (634570)
H2020 European Research Council (742432)
The Eve Appeal
- License Information
-
More Information
Article History
Received: 29 July 2020
Accepted: 3 November 2020
First Online: 23 November 2020
Ethics approval and consent to participate
: The study itself is a sub-study of the FORECEE (4C) Program, which has ethical approval from the UK Health Research Authority (REC 14/LO/1633). All participants provided written informed consent [CitationRef removed].
: AL and TP are employees of Eurofins, which offers 16S rRNA gene sequencing as a service. NC reports personal fees from Roche, Pharmamar, AstraZeneca, Clovis, Tesaro, Pfizer, Takeda and Biocad. All other authors declare no competing interests.
